Abstract
Supplementary Table 1. Estimated annual percentage change in age-standardized bladder cancer burden across 54 African countries, 2010-2023. This table presents the estimated annual percentage change (EAPC) in age-standardized incidence, prevalence, death, and disability-adjusted life-year (DALY) rates of bladder cancer across 54 African countries from 2010 to 2023 for both sexes combined. For each outcome, the table provides country-specific EAPC estimates with corresponding 95% CIs, together with the 10 countries with the largest increases and the 10 countries with the largest decreases. DALYs indicate disability-adjusted life-years; EAPC, estimated annual percentage change. Supplementary Table 2. Dynamic time warping–based trajectory clustering of bladder cancer incidence across 54 African countries, 2010-2023. This table summarizes the results of dynamic time warping–based clustering of country-level age-standardized incidence rate trajectories for bladder cancer across 54 African countries from 2010 to 2023. Countries are classified into low-stable, moderate-rising, and high-persistent trajectory groups, with corresponding baseline and end-point age-standardized incidence rates, absolute changes, and relative percentage changes. Rates are presented per 100 000 population for both sexes combined. Supplementary Table 3. Das Gupta decomposition of changes in bladder cancer burden across 54 African countries, 2010-2023. This table presents the decomposition of changes in bladder cancer incidence, prevalence, deaths, and disability-adjusted life-years (DALYs) between 2010 and 2023 across 54 African countries. For each outcome, the absolute change in counts is partitioned into contributions from population growth, population aging or age structure change, and epidemiological change in age-specific rates. Summary estimates across outcomes and country-level rankings by overall change and by each decomposition component are also provided. Analyses were based on both sexes combined. Supplementary Table 4. Counterfactual analysis of bladder cancer burden during the COVID-19 period in the African Union, 2020-2023. This table presents the results of counterfactual analyses comparing observed and expected age-standardized incidence, prevalence, death, and disability-adjusted life-year (DALY) rates of bladder cancer in the African Union during 2020 to 2023. Expected values were estimated using autoregressive integrated moving average models fitted to prepandemic trends. The table includes summary estimates for the pandemic period, model diagnostics, and year-specific observed, expected, and gap values for each outcome. Rates are presented per 100 000 population for both sexes combined. Supplementary Table 5. Projected age-standardized bladder cancer burden across Africa to 2030 under the main and sensitivity forecasting windows. This table presents projected age-standardized incidence, prevalence, death, and disability-adjusted life-year (DALY) rates of bladder cancer from 2023 to 2030 under the main forecasting model and 2 sensitivity analyses using alternative training windows. For each outcome, the table provides projected estimates with uncertainty intervals under the main model based on 2010-2023 data and sensitivity models restricted to prepandemic periods. Rates are presented per 100 000 population for both sexes combined. Supplementary Figure 1. Geographic distribution of bladder cancer burden in Africa in 2010. Maps show the age-standardized incidence, prevalence, death, and disability-adjusted life-year (DALY) rates of bladder cancer per 100 000 population across 54 African countries in 2010 for both sexes combined. Countries were grouped into 5 categories for each outcome according to the distribution of country-specific age-standardized rates. DALYs indicate disability-adjusted life-years.